in vivo tracking of glutathione

in vivo tracking of glutathione Molecular engineering to construct the high-performance activatable Near-infrared-II fluorogenic sensor for imaging and its clinical application Glutathione responsive nanomedicine leverages tumor

Name: in vivo tracking of glutathione Molecular engineering to construct the high-performance activatable Near-infrared-II fluorogenic sensor for imaging and its clinical application Glutathione responsive nanomedicine leverages tumor
Brand: clintoncounty708.com
SKU: 38919128113
Price: 23.42 USD
Availability: InStock
Rating: 4.4347 (22 reviews)

Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics Discover Oncology Springer Nature Link High fidelity optical platform for multiplex glutathione profiling links redox dynamics to tumor progression and auxiliary diagnosis ScienceDirect in vivo tracking of glutathione metabolism Organelle specific localization plants grown under different light intensities and spectra Histochemistry and Cell Biology Glutathione metabolism in brain Glutathione Homeostasis and Functions: Potential Targets for Medical Interventions Lushchak 2012 Journal of Amino Acids Wiley Online Library

SKU: 38919128113 · From clintoncounty708.com

4.4

USD23.42 USD46.42

Pay in 4 interest-free payments of $5.86 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 14 - Aug 19

Description

Phosphono analogs of glutathione: inhibition of glutathione transferases, metabolic stability, and uptake by cancer cells

Glutathione works by stimulating the production of lighter melanin pigment (pheomelanin) over its darker counterpart (eumelanin), and effectively lightens the skin and helps to boost immunity, stamina and in detoxification

However, exfoliating more regularly than once or twice a week may be damaging rather than helpful

Indeed, an optimized Fer-1 molecule with an improved ADME (absorption, distribution, metabolism, and excretion) profile is expected to move into preclinic and clinic trials [115]